Establishment and characterization of a primary human chordoma xenograft model. Laboratory investigation

Journal of Neurosurgery

Volumn 116, Issue 4, 2012, Pages 801-809

  Siu, I Mei ^a   Salmasi, Vafi ^a   Orr, Brent A ^a   Zhao, Qi ^a   Binder, Zev A ^a,b   Tran, Christine ^a   Ishii, Masaru ^a   Riggins, Gregory J ^a   Hann, Christine L ^a   Gallia, Gary L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

Author keywords

Animal model; Brachyury; Chordoma; Oncology; Xenograft

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN S 100;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHORDOMA; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CHORDOMA; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SPINAL CORD NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859354168     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.12.JNS111123     Document Type: Article

References (22)

1. Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M: Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer 110:2457-2467, 2007 (Pubitemid 350174931)
2. Butler MG, Dahir GA, Hedges LK, Juliao SF, Sciadini MF, Schwartz HS: Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas. Cancer Genet Cytogenet 85:51-57, 1995 (Pubitemid 26023370)
3. Coindre JM, Rivel J, Trojani M, De Mascarel I, De Mascarel A: Immunohistological study in chordomas. J Pathol 150:61-63, 1986 (Pubitemid 16008197)
4. Cree IA, Glaysher S, Harvey AL: Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue. Curr Opin Pharmacol 10:375-379, 2010
5. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al: A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 69:3364-3373, 2009
6. DeComas AM, Penfornis P, Harris MR, Meyer MS, Pochampally RR: Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor. J Bone Joint Surg Am 92:1231-1240, 2010
7. Hallor KH, Staaf J, Jönsson G, Heidenblad M, Vult von Steyern F, Bauer HC, et al: Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 98:434-442, 2008 (Pubitemid 351161241)
8. Henderson SR, Guiliano D, Presneau N, McLean S, Frow R, Vujovic S, et al: A molecular map of mesenchymal tumors. Genome Biol 6:R76, 2005
9. Johannsson OT, Staff S, Vallon-Christersson J, Kytöla S, Gudjonsson T, Rennstam K, et al: Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier. Lab Invest 83:387-396, 2003 (Pubitemid 36351000)
10. Johnson DR: Hairpin-tail: a case of post-reductional gene action in the mouse egg. Genetics 76:795-805, 1974
11. Kispert A, Hermann BG: The Brachyury gene encodes a novel DNA binding protein. EMBO J 12:4898-4899, 1993
12. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM: Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 12:1-11, 2001 (Pubitemid 32125896)
13. Ostroumov E, Hunter CJ: Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein. Spine (Phila Pa 1976) 33:2774-2780, 2008
14. Ostroumov E, Hunter CJ: The role of extracellular factors in human metastatic chordoma cell growth in vitro. Spine (Phila Pa 1976) 32:2957-2964, 2007
15. Pandita A, Aldape KD, Zadeh G, Guha A, James CD: Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 39:29-36, 2004 (Pubitemid 37475250)
16. Presneau N, Shalaby A, Ye H, Pillay N, Halai D, Idowu B, et al: Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 223:327-335, 2011
17. Ricci-Vitiani L, Pierconti F, Falchetti ML, Petrucci G, Maira G, De Maria R, et al: Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note. J Neurosurg 105:482-484, 2006 (Pubitemid 44358765)
18. Scheil S, Brüderlein S, Liehr T, Starke H, Herms J, Schulte M, et al: Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32: 203-211, 2001 (Pubitemid 32953974)
19. Schwab JH, Boland PJ, Agaram NP, Socci ND, Guo T, O'Toole GC, et al: Chordoma and chondrosarcoma gene profile: implications for immunotherapy. Cancer Immunol Immunother 58:339-349, 2009
20. Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, et al: Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209:157-165, 2006 (Pubitemid 43805410)
21. Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Iafrate J, et al: Characterization and analysis of human chordoma cell lines. Spine (Phila Pa 1976) 35:1257-1264, 2010
22. Zhou H, Chen CB, Lan J, Liu C, Liu XG, Jiang L, et al: Differential proteomic profiling of chordomas and analysis of prognostic factors. J Surg Oncol 102:720-727, 2010